β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces

α -Synuclein is an intrinsically disordered protein that is associated with the pathogenesis of Parkinson’s disease through the processes involved in the formation of amyloid fibrils. α and β -synuclein are homologous proteins found at comparable levels in presynaptic terminals but β -synuclein has...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 6; no. 1; p. 36010
Main Authors Brown, James W. P., Buell, Alexander K., Michaels, Thomas C. T., Meisl, Georg, Carozza, Jacqueline, Flagmeier, Patrick, Vendruscolo, Michele, Knowles, Tuomas P. J., Dobson, Christopher M., Galvagnion, Céline
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 03.11.2016
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:α -Synuclein is an intrinsically disordered protein that is associated with the pathogenesis of Parkinson’s disease through the processes involved in the formation of amyloid fibrils. α and β -synuclein are homologous proteins found at comparable levels in presynaptic terminals but β -synuclein has a greatly reduced propensity to aggregate and indeed has been found to inhibit α -synuclein aggregation. In this paper, we describe how sequence differences between α - and β -synuclein affect individual microscopic processes in amyloid formation. In particular, we show that β -synuclein strongly suppresses both lipid-induced aggregation and secondary nucleation of α -synuclein by competing for binding sites at the surfaces of lipid vesicles and fibrils, respectively. These results suggest that β -synuclein can act as a natural inhibitor of α -synuclein aggregation by reducing both the initiation of its self-assembly and the proliferation of its aggregates.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Institute of Physical Biology, University of Düsseldorf, Universitätsstr.1, 40225, Düsseldorf, Germany.
Present address: German Centre for Neurodegenerative Diseases (DZNE), Ludwig-Erhard-Allee 2, 53175 Bonn, Germany.
ISSN:2045-2322
2045-2322
DOI:10.1038/srep36010